Needham Maintains Buy on Trulieve Cannabis, Lowers Price Target to $6.5
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Matt McGinley has maintained a 'Buy' rating on Trulieve Cannabis (OTC:TCNNF) but lowered the price target from $9 to $6.5.
November 09, 2023 | 10:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst has maintained a 'Buy' rating on Trulieve Cannabis but lowered the price target from $9 to $6.5.
The news is directly related to Trulieve Cannabis (TCNNF). While the 'Buy' rating is maintained, the lowering of the price target could indicate a potential decrease in the stock's value. However, the impact on the stock price is uncertain in the short term as the 'Buy' rating might still attract investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100